$32.10
-1.20-3.60%
At close: -
$32.10
0.000.00%
After Hours: 4:43 PM EDT
Comments
Loading...
Avidity Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:RNA | Benzinga
Avidity Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.760
Quarterly Revenue Estimate
$1.96M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$10.90M
Analyze the earnings history of Avidity Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RNA | Avidity Biosciences | -$0.79 | -$0.76 | — | — | $3.54M | $1.96M | — | — | 05/08/2025 | Get Alert |
| RNA | Avidity Biosciences | -$0.79 | -$0.78 | -$0.80 | -2.56% | $2.19M | $1.62M | $2.97M | 83.52% | 02/27/2025 | Get Alert |
| RNA | Avidity Biosciences | -$0.71 | -$0.73 | -$0.65 | 10.96% | $2.82M | $4.27M | $2.34M | -45.29% | 11/07/2024 | Get Alert |
| RNA | Avidity Biosciences | -$0.66 | -$0.79 | -$0.65 | 17.72% | $2.32M | $2.64M | $2.04M | -22.54% | 08/09/2024 | Get Alert |
| RNA | Avidity Biosciences | -$0.74 | -$0.78 | -$0.79 | -1.28% | $2.23M | $2.56M | $3.54M | 38.40% | 05/09/2024 | Get Alert |
| RNA | Avidity Biosciences | -$0.88 | -$0.66 | -$0.79 | -19.70% | $2.77M | — | $2.19M | — | 02/28/2024 | Get Alert |
| RNA | Avidity Biosciences | -$0.82 | -$0.77 | -$0.71 | 7.79% | $2.48M | $1.84M | $2.82M | 53.15% | 11/08/2023 | Get Alert |
| RNA | Avidity Biosciences | -$0.92 | -$0.80 | -$0.66 | 17.50% | $2.18M | $2.14M | $2.32M | 8.22% | 08/08/2023 | Get Alert |
| RNA | Avidity Biosciences | -$0.71 | -$0.85 | -$0.74 | 12.94% | $1.79M | $2.04M | $2.23M | 9.46% | 05/09/2023 | Get Alert |
| RNA | Avidity Biosciences | -$0.82 | -$0.89 | -$0.88 | 1.12% | $1.85M | $2.31M | $2.77M | 19.87% | 02/28/2023 | Get Alert |
| RNA | Avidity Biosciences | -$0.68 | -$0.93 | -$0.82 | 11.83% | $2.16M | $2.37M | $2.48M | 4.73% | 11/08/2022 | Get Alert |
| RNA | Avidity Biosciences | -$0.70 | -$0.75 | -$0.92 | -22.67% | $2.61M | $2.06M | $2.18M | 5.73% | 08/09/2022 | Get Alert |
| RNA | Avidity Biosciences | -$0.64 | -$0.80 | -$0.71 | 11.25% | $2.70M | $1.90M | $1.79M | -5.53% | 05/10/2022 | Get Alert |
| RNA | Avidity Biosciences | -$0.43 | -$0.70 | -$0.82 | -17.14% | $2.14M | $2.17M | $1.85M | -14.65% | 03/01/2022 | Get Alert |
| RNA | Avidity Biosciences | -$0.31 | -$0.68 | -$0.68 | 0.00% | $1.75M | $2.12M | $2.16M | 2.03% | 11/09/2021 | Get Alert |
| RNA | Avidity Biosciences | -$1.23 | -$0.71 | -$0.70 | 1.41% | $1.54M | $1.94M | $2.61M | 34.38% | 08/09/2021 | Get Alert |
| RNA | Avidity Biosciences | -$2.14 | -$0.56 | -$0.64 | -14.29% | $1.36M | $1.00M | $2.70M | 170.40% | 05/12/2021 | Get Alert |
| RNA | Avidity Biosciences | — | -$0.34 | -$0.43 | -26.47% | — | $840.00K | $2.14M | 155.00% | 03/15/2021 | Get Alert |
| RNA | Avidity Biosciences | -$2.43 | -$0.37 | -$0.31 | 16.22% | $650.00K | $570.00K | $1.75M | 206.32% | 11/10/2020 | Get Alert |
| RNA | Avidity Biosciences | -$1.19 | -$0.37 | -$1.23 | -232.43% | $224.00K | $570.00K | $1.54M | 170.35% | 08/10/2020 | Get Alert |
Avidity Biosciences (RNA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.80 | $-0.78 | -2.56 % |
| Q3 | 2024-11-07 | $-0.65 | $-0.73 | 11.0 % |
| Q2 | 2024-08-09 | $-0.65 | $-0.79 | 17.7 % |
| Q1 | 2024-05-09 | $-0.79 | $-0.78 | -1.28 % |
Avidity Biosciences (RNA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $2.97M | $1.62M | 83.5 % |
| Q3 | 2024-11-07 | $2.34M | $4.27M | -45.3 % |
| Q2 | 2024-08-09 | $2.05M | $2.64M | -22.5 % |
| Q1 | 2024-05-09 | $3.54M | $2.56M | 38.4 % |
FAQ
When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?
Avidity Biosciences (RNA) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Avidity Biosciences (NASDAQ:RNA)?
The Actual EPS was $-0.80, which missed the estimate of $-0.78.
What were Avidity Biosciences’s (NASDAQ:RNA) revenues?
The Actual Revenue was $3M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.